Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610539 · ClinicalTrials.gov registry record

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

A clinical trial of Breast Cancer, sponsored by Endomagnetics.

Recruiting
Registry status
184
Enrollment target
2
Study locations

NCT06610539 is a study of Breast Cancer that is actively recruiting participants, run by Endomagnetics. The registered enrollment target is 184 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06610539, a study of Breast Cancer, is actively recruiting participants, sponsored by Endomagnetics.

RECRUITING
Registry status
184 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur using patient reported outcome measures.

Conditions Studied

Breast Cancer

Study Locations (2)

North Carolina

  • UNC, Lineberger Comprehensive Cancer Center - Chapel Hill

Virginia

  • VCU Massey Comprehensive Cancer Center - Richmond

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2025-04-22
Est. Completion 2028-11

Sponsor

Endomagnetics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06610539

The ClinicalTrials.gov registry entry for NCT06610539 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Endomagnetics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT06610539 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Virginia.

Frequently Asked Questions

What is clinical trial NCT06610539 about?

NCT06610539 is a clinical study titled "PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients". The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on patie...

What is the current status of trial NCT06610539?

This trial is currently recruiting. The enrollment target is 184 participants. The study started on 2025-04-22. Estimated completion is 2028-11.

What conditions does trial NCT06610539 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT06610539?

This trial is sponsored by Endomagnetics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610539 being conducted?

This trial has 2 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.